In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis
- PMID: 11861273
- DOI: 10.1182/blood.v99.5.1594
In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis
Abstract
Erythropoiesis results from the proliferation and differentiation of pluripotent stem cells into immature erythroid progenitors (ie, erythroid burst-forming units (BFU-Es), whose growth, survival, and terminal differentiation depends on erythropoietin (Epo). Ineffective erythropoiesis is a common feature of myelodysplastic syndromes (MDS). We used a 2-step liquid-culture procedure to study erythropoiesis in MDS. CD34(+) cells from the marrow of patients with MDS were cultured for 10 days in serum-containing medium with Epo, stem cell factor, insulin-like growth factor 1, and steroid hormones until they reached the proerythroblast stage. The cells were then placed in medium containing Epo and insulin for terminal erythroid differentiation. Numbers of both MDS and normal control cells increased 10(3) fold by day 15. However, in semisolid culture, cells from patients with refractory anemia (RA) with ringed sideroblasts and RA or RA with excess of blasts produced significantly fewer BFU-Es than cells from controls. Fluorescence in situ hybridization analysis of interphase nuclei from patients with chromosomal defects indicated that abnormal clones were expanded in vitro. Epo-signaling pathways (STAT5, Akt, and ERK 1/2) were normally activated in MDS erythroid progenitors. In contrast, apoptosis was significantly increased in MDS cells once they differentiated, whereas it remained low in normal cells. Fas was overexpressed on freshly isolated MDS CD34(+) cells and on MDS erythroid cells throughout the culture. Apoptosis coincided with overproduction of Fas ligand during the differentiation stage and was inhibited by Fas-Fc chimeric protein. Thus, MDS CD34(+)-derived erythroid progenitors proliferated normally in our 2-step liquid culture with Epo but underwent abnormal Fas-dependent apoptosis during differentiation that could be responsible for the impaired erythropoiesis.
Similar articles
-
Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.Br J Haematol. 1999 Aug;106(2):464-73. doi: 10.1046/j.1365-2141.1999.01539.x. Br J Haematol. 1999. PMID: 10460607
-
Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.Blood. 2005 May 15;105(10):4035-42. doi: 10.1182/blood-2004-08-3166. Epub 2005 Jan 27. Blood. 2005. PMID: 15677568
-
The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.J Cancer Res Clin Oncol. 1995;121(6):338-42. doi: 10.1007/BF01225685. J Cancer Res Clin Oncol. 1995. PMID: 7797598
-
Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.Med Oncol. 2006;23(1):37-49. doi: 10.1385/MO:23:1:137. Med Oncol. 2006. PMID: 16645228 Review.
-
Luspatercept in Myelodysplastic Syndromes: Who and When?Hematol Oncol Clin North Am. 2020 Apr;34(2):393-400. doi: 10.1016/j.hoc.2019.10.004. Epub 2020 Jan 21. Hematol Oncol Clin North Am. 2020. PMID: 32089218 Review.
Cited by
-
Blockade of the interaction between BMP9 and endoglin on erythroid progenitors promotes erythropoiesis in mice.Genes Cells. 2021 Oct;26(10):782-797. doi: 10.1111/gtc.12887. Epub 2021 Aug 12. Genes Cells. 2021. PMID: 34333851 Free PMC article.
-
Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.PLoS One. 2009 Dec 24;4(12):e8446. doi: 10.1371/journal.pone.0008446. PLoS One. 2009. PMID: 20041181 Free PMC article.
-
The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome.Int J Mol Sci. 2020 Apr 25;21(9):3033. doi: 10.3390/ijms21093033. Int J Mol Sci. 2020. PMID: 32344823 Free PMC article.
-
APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.Oncotarget. 2016 Mar 22;7(12):14898-911. doi: 10.18632/oncotarget.7469. Oncotarget. 2016. PMID: 26910909 Free PMC article.
-
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?Exp Hematol. 2013 Aug;41(8):665-74. doi: 10.1016/j.exphem.2013.04.008. Epub 2013 Apr 30. Exp Hematol. 2013. PMID: 23643835 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous